As part of the Company’s acceptance to Luminate, Augmentiqs has announced the addition of digital microscope advisory members to the Company’s board. This move to supplement the digital microscope add-on company with a highly talented and successful group of advisers to assist in sales & business development will play a significant role in advancing Augmentiqs in the global microscope market.

• Sujatha Ramanujan is a serial entrepreneur with 25 years of experience in Clinical Devices and in Consumer Electronics. Sujatha has started, built and grown three startup businesses in cardiac surgical equipment, optical communications and nano materials.
• Dr. Ryne Raffaelle is the VP for Research and Associate Provost at Rochester Institute of Technology (RIT). He is the former Director of the National Center for Photovoltaics at the National Renewable Energy Lab of the U.S. Department of Energy.
• Jay Kumler is President of Jenoptik Optical Systems, the US optics operations of Jenoptik AG. Prior to its acquisition by Jenoptik, Jay founded and led Coastal Optical Systems for 10 years, and previously designed optical systems for United Technologies and Bell Laboratories.
• Don Golini is a successful entrepreneur with extensive experience in the development, management and commercialization of new technologies. As president and founder of QED Technologies, Don licensed a university technology and developed products that succeeded in global markets.

Sujatha Ramanujan, the managing director of Luminate, said about Augmentiqs, “Augmentiqs is an innovative optics startup that is bridging the world of digital health with the analog microscope and pathology workflow. The addition of digital microscope component within the classic pathology workflow promises to be a game changes for the LIS, similar to what the PACS did to radiology. We’re happy that Augmentiqs is part of the Luminate accelerator, and I am certain the company will be successful as it progresses in its development.”

For more information on the Augmentiqs board of advisers, click here.